Table: AFC-HD Ams Life Science -Q1 group results

AFC-HD AMS Life Science

14/01/2025 06:32

Jan 14 (Reuters)- 
             AFC-HD Ams Life Science Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Nov 30, 2024        Nov 30, 2023     Aug 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               8.19                6.79             31.10    
                   (+20.7 pct)         (+19.3 pct)      (+3.0 pct)  
  Operating          650 mln             478 mln            2.20    
                   (+35.9 pct)        (+115.9 pct)      (+14.8 pct) 
  Recurring          704 mln             489 mln            2.20    
                   (+44.0 pct)        (+106.9 pct)      (+14.5 pct) 
  Net                460 mln             318 mln            1.32    
                   (+44.5 pct)         (+98.3 pct)      (+5.4 pct)  
  EPS               32.70 yen           22.80 yen        93.78 yen  
  EPS Diluted       32.69 yen           22.79 yen                   
  Ann Div                               30.00 yen        32.00 yen  
  -Q2 div                               15.00 yen        16.00 yen  
  -Q4 div                               15.00 yen        16.00 yen  
  
  NOTE - AFC-HD Ams Life Science Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T